BioCentury

1:21 AM GMT, Jun 12, 2007
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

Ipsen discontinuing four-month formulation of Decapeptyl

Ipsen (Euronext:IPN) will discontinue an open-label, single-arm Phase III trial

Read the full 105 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.